Brigham and Women's Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Brigham and Women's Hospital sits in the top decile of US sponsors by registered trial count (#35 of 15,742 sponsors by registered trial count).
Brigham and Women's Hospital: 937 sponsored US clinical trials, 145 recruiting.
Brigham and Women's Hospital sponsors 937 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 608 completed. 124 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 13 trials.
Top-decile sponsor footprint
Brigham and Women's Hospital ranks in the top decile of sponsors by registered trial count (#35 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
608 of 677 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
937 total, page 19 of 19
The Effects of Modafinil to Counteract the Adverse Metabolic Consequences of Sleep Restriction
NCT00895570
Rho Kinase in Patients With Atherosclerosis
NCT00115830
Testosterone Replacement in Older Men and Atherosclerosis Progression
NCT00287586
Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial
NCT00476619
Hypoglycemia and Autonomic Nervous System Function
NCT01816893
Acupuncture Analgesia in Relation to Psychiatric Comorbidity
NCT00307788
Ventricular-Vascular Coupling in Heart Failure
NCT00207220
ARREST PAD (Peripheral Arterial Disease)
NCT00153166
Patient- and Physician-Based Osteoporosis Education
NCT00073190
Preventing Obesity Using Novel Dietary Strategies
NCT00072995
Aldosterone and Vascular Disease in Diabetes Mellitus
NCT00214825
Comparison of Crinone 8% Intravaginal Gel and IM Progesterone Supplementation for In Vitro Fertilization (IVF)
NCT00656201
Impact of Sleep Disruption on the Menstrual Cycle
NCT00456222
The Impact of Pharmacist Recommendations on Quality of Care in Diabetic Patients
NCT00122421
Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial
NCT02218203
Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction
NCT00119691
Predicting the Response to Montelukast by Genetic Variation in Asthmatics
NCT00116324
Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan Dose Response Clinical Trial
NCT01435798
Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
NCT00054938
A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced Vasospasm
NCT00235963
Impact of Literacy Level on Patient Education and Health Among People With Arthritis
NCT00023205
The Effect of Fasudil on Vascular Function in Humans
NCT00120718
The Role of Mineralocorticoid Receptors in Vascular Function
NCT00759525
Neurosurgical Use of Interstitial Laser Therapy (ILT)
NCT00207350
Relaxation Response Training for the Treatment of Rheumatoid Arthritis
NCT00056667
Study to Evaluate the Efficacy of Dronabinol (Marinol) as Add-On Therapy for Patients on Opioids for Chronic Pain
NCT00153192
Imaging of Plaque With Magnetic Resonance Imaging (MRI)
NCT00115856
Soy Isoflavone Tablets: Effects on Sleep, Quality of Life, Symptoms and Cognitive Function in Menopausal Women
NCT01401946
Vascular Dysfunction in Diabetes: Genes and Hormones
NCT01511042
Genetic Mechanisms in Human Hypertension
NCT01456208
Signaling Mechanisms and Vascular Function in Patients With Diabetes Mellitus
NCT00762671
The Role of Endothelin in Pulmonary Hypertension
NCT00759408
The Contribution of Endothelin to Vasomotor Function in Diseased Coronary Arteries
NCT00115583
Lyme Disease Prevention Program
NCT00000432
Psychoeducational Approach to Improve Health in Lupus
NCT00000417
Evaluating the Relationship Between Fatty Acids and Heart Disease
NCT00404872
The Effects of a Results Management System on Physician Awareness of Post-Discharge Test Results
NCT00146354
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 90 |
| Phase 2 | 107 |
| Phase 3 | 47 |
| Phase 4 | 77 |
Therapeutic Areas
What is open in the Brigham and Women's Hospital pipeline
145 recruiting of 937 indexed (15% open); 608 completed (65%).
Phase mix: 124 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Brigham and Women's Hospital: open-pipeline peers nationwide
Peers matched on 937 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Brigham and Women's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 937 trials (± recruiting share)
- Columbia University · 958 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of Minnesota · 966 trials · 19% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Incyte Corporation · 15% recruiting · 239 trials
- Northwestern University · 15% recruiting · 1,209 trials
- Nationwide Children's Hospital · 15% recruiting · 188 trials
- University of Michigan Rogel Cancer Center · 15% recruiting · 292 trials
Related
What to do with this Brigham and Women's Hospital page
937 registered trials is a research-attention snapshot, not an endorsement of Brigham and Women's Hospital or any single study.
- 145 of Brigham and Women's Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition Brigham and Women's Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Brigham and Women's Hospital pipeline card: 937 registered trials from official public datasets.Report a data error.